Clinical Trial Update: Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates adding AZD1656 to metformin in type 2 diabetes mellitus, reporting on efficacy, safety and tolerability with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2012-11-26